Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
4
80%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Other(4)

Detailed Status

unknown4
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 14 (80.0%)
N/A1 (20.0%)

Trials by Status

unknown480%
completed120%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

C-CAR011 Treatment in Subjects With ALL After HSCT

NCT03327285
completedphase_1

A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects

NCT02976857
unknownphase_1

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

NCT03299738
unknownphase_1

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

NCT03154775
unknownphase_1

A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL

NCT03018093

Clinical Trials (5)

Showing 5 of 5 trials
NCT03327285Not Applicable

C-CAR011 Treatment in Subjects With ALL After HSCT

Unknown
NCT02976857Phase 1

A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects

Completed
NCT03299738Phase 1

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Unknown
NCT03154775Phase 1

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

Unknown
NCT03018093Phase 1

A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5